PPT-Abnormal Uterine

Bleeding and Associated Anomalies Evidence and Treatment Tamara N FullerEddins MD Assistant Clinical Professor Obstetrics and Gynecology University of South Dakota Sanford School of Medicine. Maria C. Monge, MD. Director of Adolescent Medicine. Dell Children’s Medical Center. UTSW-Austin Pediatrics Residency Program. Lone Star Circle of Care. Disclosures. I have no relevant financial disclosures.. Sonnie. Kim-. Ashchi. , MD. FACOG. Patient No 1. Emily is 14 years old, started her first menses last year, irregular at the beginning , now regular monthly. But she reports heavy bleeding that soaks through her uniform. And very “ inconvenient” to have heavy bleeding during her soccer/ lacrosse/crew practices. Lesley K. . Bicanovsky. , DO. Cleveland Clinic. January 25, 2013. CAOM 48. th. Annual January Seminar. OBJECTIVES. To understand the terminology of abnormal uterine bleeding.. To review the etiology of abnormal uterine bleeding.. pulsatility . index (PI) . at . 11 0 . to . 13 6 weeks’ gestation. Indication: . To screen . in the first trimester for . pre-eclampsia and/or fetal growth . restriction. Machine settings: . Routine . Patient Presentation. 58 year-old female with history of fibroids presented to UVA Ob/. Gyn. clinic by self-referral in June 2014 for 9 months of intermittent post-menopausal bleeding. Endorsed progressive pelvic cramping, early satiety, and increasing abdominal girth. Heather Paladine, MD, MEd, FAAFP. What You Need to Know. Uterine cancer overview. Abnormal uterine bleeding (pre-menopausal). Evaluation. Treatment. Post-menopausal bleeding. Evaluation. Treatment. Caring for patients after diagnosis. Objectives. To define normal and abnormal. To decide between methods of deciding normality. To recognize the use of the bell-shaped curve showing normal distribution. To develop and analyze surveys to determine normal personality qualities and behaviors. What is 200 mg (1 tablet) stops the action of the hormone that sustains pregnancy (progesterone). This causes the embryo to detach from the uterus and the pregnancy to stop ZUMI 4.5 ™ For such procedures as Minilaparotomy, Salpingoplasties and Fertility Examinations REF ZSI1151 Instructions For Use DESCRIPTION ZUMI 4.5 (Zinnanti Uterine Manipulator-Injector) is a CAUSES OF ABNORMAL BEHAVIOR. Biological/Genetic . View as mental disorder – similar to physical disorders . Diagnosis and treatment . Nervous system and the brain. CAUSES OF ABNORMAL BEHAVIOR. Cognitive –Emotional . Lecturer. Nightingale Institute of Nursing. Introduction. Uterine malformations result from partial or complete failure of one of three mechanisms either separately or combined - agenesis, fusion, and resorption. . TRACT. THEY . OCCUR IN 20-30% OF WOMEN ABOVE THE AGE OF 30 . YEARS. UTERINE FIBROID. THEY . ARE ABOUT 3-9 TIMES MORE COMMON IN THE BLACK THAN IN THE . WHITES. THEY ARE USUALLY MULTIPLE AND OF VARIOUS SIZES 90% OF THEM CEASE TO GROW AND EVEN REGRESS AFTER . VOLUME 23, NO. 5 OCTOBER 1982 DISCUSSION It is impossible to assess the incidence of uterine perfora- tions which occur in a dilatation and curettage. Often the accident is not recognised by the surge Al-Qahtani. Obstetrician and Gynecologist. Kuwaiti Board . Maternity . H. ospital. Abnormal uterine bleeding. Abnormal uterine bleeding. Abnormal uterine bleeding is a term . which refers to menstrual bleeding of abnormal quantity, duration, or schedule.